Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 2 news outlets

twitter: 6 X users

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 49 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy

Cancer Cell International, 09 Apr 2024

Abstract Extensive exploration of the molecular subtypes of triple-negative breast cancer (TNBC) is critical for advancing…

A new weapon to boost cancer immunotherapy

Medium US, 17 Nov 2020

2 hours ago · 9 min read In recent years, immunooncology has paved new avenues for effective treatment across cancer types.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.